bioecon 会员专区
供应商 · 生产商 · 食品生物技术

Changjin Bio 昌进生物 (Shanghai)

Changing Bio 兼具生物质发酵与精密发酵能力,使用专有菌株在受控、高效条件下生产非转基因菌蛋白及系列乳蛋白;与传统农业相比,其生物反应器占地仅为其零头,碳排放降低多个数量级。公司目前处于 A+ 轮融资阶段,投资方包括高瓴(Hillhouse)、Bits x Bites、富达(Fidelity)等。

运营中 中国亚洲 成立 2017 核实于 2026-10-05

简介

Shanghai Changjin Biotechnology (Changjin Bio) is a Chinese food technology company founded in 2017 and headquartered in Shanghai’s Zhang江 Science City. It specializes in synthetic biology, focusing on the research, development, and industrialization of microbial biomass proteins and recombinant milk proteins.

The company’s core technology utilizes precision fermentation to produce proteins, such as beta-lactoglobulin and Kluyveromyces marxianus microbial protein, which are used in food products like protein crisps, cookies, and dairy alternatives. Its subsidiary brand, Chuangshenghuo, markets these as “yuan protein” products.

Changjin Bio is active as of September 2026. In October 2025, its beta-lactoglobulin and Kluyveromyces marxianus protein received U.S. market access via FDA GRAS status. The company has secured nearly 300 million RMB in funding across multiple rounds from investors including Hillhouse Investment and Sherpa Invest. It operates a production facility in Qingdao and maintains various international certifications, including FSSC22000, BRC, and Halal.

Sources#

行业
能源, 食品配料, 废弃物与循环经济
主题
精密发酵(蛋白质、乳制品、蛋类), 生物质、蔗渣与废弃物高值化利用, 酵母、发酵与食品配料
角色
生产商 — “…st [2][7][8]. It operates a production facility in Qingdao and maintains various international certifications,…”

供应的生物解决方案 1

产品与服务

子公司: Qingdao Changjin Biotechnology Co., Ltd. (Qingdao 昌进生物科技有限公司)

新闻与状态 6

关系网络:股东、合作伙伴、同类

股权与投资方 5

投资方GL Ventures
投资方Qingdao City Construction Investment Financial Holdings
投资方Bits x Bites
投资方Hillhouse/高瓴系
子公司Qingdao Changjin Biotechnology Co., Ltd

同类企业

SYNAURA Biotech · Yakult Honsha Co., Ltd. · Laurus Bio · 黑龙江康普生物科技有限公司 · FEBICO遠東生技 · Zhuhai TXY Biotech Holding Co., Ltd. · CJ BIO Taste & Nutrition Indonesia · Eppen Biotech

身份与联系方式

联系方式、人员和法律信息仅向会员开放。

会员登录